Similarly, the binding sites between PPARα and pemafibrate, also known as K-877 with higher efficacy in reducing TG levels compared to other fibrates, expand into the Arm III domain [42]; this suggests that herpetrione could be a potential PPARα ligand for managing NASH. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.